Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Mela Sciences Shares Surge After FDA Approves Cancer Test

Nov. 2 (Bloomberg) -- Mela Sciences Inc., the maker of the MelaFind melanoma-detection device, gained 19 percent after receiving Food and Drug Administration approval to sell the product in the U.S.

Mela rose to $6.42 at 8:10 a.m. The Irvington, New York-based company said in a statement today that it plans to first introduce the test in the northeastern U.S. in 2012.

To contact the reporter on this story: Bruce Rule in New York at brule1@bloomberg.net

To contact the editor responsible for this story: Reg Gale at Rgale5@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.